Sunovion CNS Development Canada ULC (formerly Cynapsus Therapeutics Inc.)
Profile
Mailing Address: 1600 - 925 West Georgia Street
Vancouver, British Columbia
V6C 3L2
Head Office Address: 1600 - 925 West Georgia Street
Vancouver, British Columbia
V6C 3L2
Contact Name: Gregory Bokar Principal Regulator: British Columbia
Business e-mail address: Gregory.bokar@sunovion.com Short Form Prospectus Issuer: Yes
Telephone Number: 508 481-6700 Reporting Jurisdictions: Ceased Reporting
Fax Number: 508 357-7511 Stock Exchange: N/A
Date of Formation: Oct 21 2016 Stock Symbol:
Jurisdiction Where Formed: British Columbia Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: Transfer Agent: TSX Trust Company
Financial Year-End: Mar 31 Size of Issuer (Assets): $5,000,001 to $25,000,000


View This Company's Documents